Pilot Study on Online Tool to Enhance Cascade Screening for Lynch Syndrome
A pilot study is testing an online intervention, Let's Talk, to improve cascade screening uptake among relatives of Lynch syndrome patients.
Phase III
UNC Lineberger Comprehensive Cancer Center
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The pilot study on the Let's Talk tool aims to enhance cascade screening for Lynch syndrome, addressing a significant gap in genetic testing uptake. If successful, this intervention could reshape the competitive landscape for genetic counseling and genetic testing services, making it crucial for pharma strategy teams to monitor its outcomes closely.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the study's implementation and effectiveness outcomes, as well as any subsequent adoption of the tool in clinical practice.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.